Hong Kong
· Delayed Price · Currency is HKD The United Laboratories International Holdings Company Description
The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, amoxicillin products, nervous system drugs, vitamins, veterinary drugs, and vacant gelatin capsules.
It also provides intermediate products, such as 6-aminopenicillanic acid, tert-octylammonium clavulanate, anhydrous sodium carbonate sterile, and penicillin G potassium first crystal.
In addition, the company manufactures and sells soft capsules casings; holds trademarks; and trades in pharmaceutical products, as well as offers management services.
It has operations in the People's Republic of China, India, Europe, the Middle East, South America, rest of Asian regions, and internationally.
The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong.
| Country | Cayman Islands |
| Founded | 1990 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 15,000 |
Contact Details
Address: 6 Fuk Wang Street Yuen Long Hong Kong | |
| Phone | 852 2687 1033 |
| Website | tul.com.cn |
Stock Details
| Ticker Symbol | 3933 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | KYG8813K1085 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Hoi Shan Tsoi | Executive Chairman |
| Wing Hon Leung CPA, FCPA | Vice Chairman, Chief Financial Officer and Company Secretary |
| Su Yan Zhu | Vice President and Executive Director |
| Xian Hong Zou | Vice President and Executive Director |
| Siu Chit Choy | Global Director of Intermediate and Bulk Medicine and Executive Director |
| Yu Ping Fang | Vice President and Executive Director |
| Karen Yang | Investor Relationship Director |